| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| MNKD MannKind Corp | 4,027,322,656.12 | 11,344,137,622.1 | 15,637,362,460.93 |
| ADPT Adaptive Biotechnologies Corp | 1,739,824,125.98 | 8,897,179,977.75 | 15,509,959,560.41 |
| CGEM Cullinan Therapeutics Inc | 3,266,793,728.57 | 10,819,288,253.72 | 15,304,976,829.13 |
| CELC Celcuity Inc | 2,347,374,732.03 | 15,032,182,876.61 | 15,048,210,983.45 |
| GLUE Monte Rosa Therapeutics Inc | 6,586,477,048.36 | 12,702,891,136.92 | 14,537,239,995.55 |
| VCEL Vericel Corp | 3,174,102,586.05 | 7,017,181,047.56 | 14,329,633,333.57 |
| ALLO Allogene Therapeutics Inc | 1,195,469,152.23 | 8,242,272,164.51 | 13,902,754,582.74 |
| SANA Sana Biotechnology Inc | 3,267,489,228.28 | 5,113,788,036.39 | 13,765,583,072.72 |
| ORIC Oric Pharmaceuticals Inc | 1,570,185,425.18 | 9,344,797,265.24 | 13,631,541,311.37 |
| NKTX Nkarta Inc | 1,900,421,330.62 | 9,145,030,781.75 | 13,506,477,818.94 |
| COGT Cogent Biosciences Inc | 3,961,092,116.02 | 12,558,322,039.12 | 13,465,285,268.22 |
| ERAS Erasca Inc | 2,220,224,740.48 | 9,481,715,866.28 | 13,290,398,706.01 |
| TRDA Entrada Therapeutics Inc | 2,949,108,431.45 | 10,693,529,261.58 | 13,053,201,692.94 |
| SRRK Scholar Rock Holding Corp | 9,065,838,656.24 | 12,351,790,240.32 | 13,015,897,617.85 |
| BHVN Biohaven Ltd | 5,843,683,363.29 | 10,230,642,594.2 | 12,933,860,266.26 |
| PHVS Pharvaris NV | 12,216,864,235.05 | 12,510,010,908.99 | 12,573,427,103.92 |
| ZYME Zymeworks Inc | 2,049,637,630.99 | 9,222,073,180.91 | 12,559,112,379.7 |
| PRAX Praxis Precision Medicines Inc | 4,727,090,200.34 | 8,657,200,965.86 | 12,531,260,777.87 |
| KMDA Kamada Ltd | 2,276,086,012.25 | 6,093,020,007.57 | 11,924,974,716.74 |
| ARQT Arcutis Biotherapeutics Inc | 1,489,633,913.88 | 11,040,235,864.58 | 11,727,927,004.83 |
| RCKT Rocket Pharmaceuticals Inc | 2,400,991,436.57 | 7,197,789,675.53 | 11,634,856,498.84 |
| STOK Stoke Therapeutics Inc | 2,636,386,473.13 | 8,612,720,598.35 | 11,389,250,262.06 |
| ANAB AnaptysBio Inc | 3,472,219,050.57 | 10,453,044,431.72 | 11,162,707,039.93 |
| PRTA Prothena Corporation PLC | 10,459,145,860.96 | 10,747,809,852.2 | 11,147,848,637.14 |
| OLMA Olema Pharmaceuticals Inc | 1,114,696,345.57 | 10,569,350,950.59 | 11,142,316,253.12 |
| FATE Fate Therapeutics Inc | 1,284,208,591.88 | 6,994,545,693.52 | 10,864,685,416.29 |
| CLLS Cellectis SA | 6,076,865,446.24 | 6,992,712,103.39 | 10,844,895,288.31 |
| AVIR Atea Pharmaceuticals Inc | 2,445,124,054.22 | 10,626,539,994.53 | 10,842,302,971.23 |
| ALEC Alector Inc | 2,418,536,997.31 | 9,496,258,132.84 | 10,599,573,574.14 |
| REPL Replimune Group Inc | 3,886,926,556.55 | 8,863,005,651.33 | 10,545,988,483.23 |
| ZNTL Zentalis Pharmaceuticals Inc | 1,235,207,476.29 | 9,114,270,726.61 | 10,345,558,113.66 |
| MDXG MiMedx Group Inc | 4,491,758,391.03 | 8,032,863,526.02 | 10,084,366,360.76 |
| SEER Seer Inc | 1,421,759,465.38 | 6,776,791,058.57 | 9,756,216,954.44 |
| GHRS GH Research PLC | 7,892,467,426.46 | 9,319,379,912.38 | 9,548,009,633.63 |
| TYRA Tyra Biosciences Inc | 1,958,495,555.99 | 8,890,256,594.32 | 9,542,603,704.1 |
| TERN Terns Pharmaceuticals Inc | 4,764,109,752.83 | 9,493,412,906.77 | 9,536,280,979.51 |
| IMNM Immunome Inc | 8,619,106,550.19 | 8,849,411,793.46 | 9,464,391,600.9 |
| ADCT ADC Therapeutics SA | 7,420,918,626.38 | 9,077,820,219.34 | 9,160,300,161.64 |
| VYGR Voyager Therapeutics Inc | 1,426,564,736.07 | 6,941,877,397.67 | 9,114,555,249.22 |
| ARCT Arcturus Therapeutics Holdings Inc | 5,701,833,037.07 | 7,878,114,841.63 | 8,925,885,147.4 |
| PLRX Pliant Therapeutics Inc | 2,963,208,107.29 | 7,763,926,435.5 | 8,744,328,110.74 |
| LQDA Liquidia Corp | 4,979,019,161.71 | 7,167,408,983.87 | 8,724,759,278.12 |
| SLDB Solid Biosciences Inc | 1,939,938,359.32 | 7,740,658,809.0 | 8,659,413,919.47 |
| MGNX MacroGenics Inc | 2,533,167,994.16 | 7,337,237,366.41 | 8,559,799,393.52 |
| CCCC C4 Therapeutics Inc | 1,859,165,552.65 | 6,539,720,500.0 | 8,393,037,532.4 |
| XOMA Xoma Royalty Corp | 1,428,588,007.94 | 3,499,849,357.03 | 8,319,156,495.55 |
| TCRX TScan Therapeutics Inc | 5,358,698,773.46 | 5,948,577,364.27 | 8,289,882,280.69 |
| EYPT EyePoint Inc | 2,357,649,159.49 | 6,831,893,603.39 | 7,956,990,830.92 |
| ABSI Absci Corp | 299,570,691.17 | 5,532,194,336.26 | 7,745,084,716.22 |
| WVE WAVE Life Sciences Ltd | 6,203,161,869.97 | 6,812,356,384.4 | 7,630,833,082.84 |
| IMRX Immuneering Corp | 7,194,093,410.74 | 7,242,738,873.07 | 7,620,662,031.92 |
| PHAT Phathom Pharmaceuticals Inc | 4,272,770,824.78 | 6,568,773,419.5 | 7,596,405,847.44 |
| AGEN Agenus Inc | 109,319,908.2 | 4,234,644,795.49 | 7,394,141,887.74 |
| CMPX Compass Therapeutics Inc. | 1,460,928,744.23 | 6,990,404,308.92 | 7,310,934,832.11 |
| ABEO Abeona Therapeutics Inc | 2,620,263,525.42 | 6,832,652,330.34 | 7,305,750,197.94 |
| ANNX Annexon Inc | 4,407,539,699.46 | 6,095,802,006.39 | 7,244,008,792.3 |
| KOD Kodiak Sciences Inc | 2,277,382,170.79 | 2,394,036,439.51 | 6,893,951,145.26 |
| ACIU AC Immune SA | 1,101,679,252.96 | 4,517,198,670.08 | 6,815,034,481.89 |
| FULC Fulcrum Therapeutics Inc | 1,488,306,141.71 | 6,508,075,263.41 | 6,792,439,801.94 |
| MXCT MaxCyte Inc | 410,123,530.66 | 3,940,480,033.85 | 6,748,749,775.01 |
| DSGN Design Therapeutics Inc | 476,986,343.22 | 6,608,163,993.71 | 6,694,816,934.24 |
| TIL Instil Bio Inc | 183,390,626.79 | 6,204,616,096.62 | 6,694,753,706.99 |
| VTYX Ventyx Biosciences Inc | 1,010,687,526.03 | 6,357,309,895.52 | 6,685,174,779.24 |
| TNGX Tango Therapeutics Inc | 1,844,275,536.24 | 5,177,647,554.77 | 6,643,160,274.32 |
| STRO Sutro Biopharma Inc | 2,084,191,320.88 | 5,757,251,718.11 | 6,628,048,962.55 |
| GOSS Gossamer Bio Inc | 282,404,493.9 | 6,448,831,333.99 | 6,601,556,746.51 |
| LXRX Lexicon Pharmaceuticals Inc | 1,569,806,061.7 | 3,873,522,380.42 | 6,510,098,535.28 |
| PBYI Puma Biotechnology Inc | 1,692,119,168.93 | 4,539,083,984.6 | 6,413,202,780.91 |
| EDIT Editas Medicine Inc | 5,236,733,416.08 | 5,592,165,379.02 | 6,378,080,045.8 |
| NAUT Nautilus Biotechnology Inc | 754,775,248.17 | 4,246,499,904.1 | 6,351,651,057.01 |
| TRVI Trevi Therapeutics Inc | 1,797,835,124.11 | 6,268,949,819.35 | 6,302,365,418.81 |
| CRBU Caribou Biosciences Inc | 352,302,214.27 | 4,916,108,052.02 | 6,164,150,659.23 |
| AURA Aura Biosciences Inc | 1,503,322,612.62 | 5,378,109,537.96 | 6,007,347,089.35 |
| CABA Cabaletta Bio Inc | 1,903,329,783.93 | 5,202,369,407.92 | 5,998,969,479.27 |
| MGTX MeiraGTx Holdings PLC | 469,177,778.35 | 1,080,363,951.04 | 5,989,864,755.85 |
| ANIK Anika Therapeutics Inc | 1,833,273,995.45 | 3,211,627,956.51 | 5,988,789,892.67 |
| URGN Urogen Pharma Ltd | 2,846,458,997.7 | 5,328,349,695.42 | 5,849,974,474.26 |
| SABS SAB Biotherapeutics Inc | 930,221,687.65 | 3,581,088,464.63 | 5,799,467,601.81 |
| FBIO Fortress Biotech Inc | 2,725,663,344.37 | 3,746,309,161.63 | 5,734,932,500.3 |
| INBX Inhibrx Biosciences Inc | 4,839,666,311.7 | 5,103,165,859.07 | 5,610,501,280.33 |
| VSTM Verastem Inc | 4,353,385,563.33 | 4,870,268,298.73 | 5,590,932,447.72 |
| VOR Vor Biopharma Inc | 5,072,785,167.41 | 5,452,907,369.88 | 5,571,490,069.6 |
| XBIT XBiotech Inc | 4,658,804,774.75 | 4,708,880,753.51 | 5,450,947,325.26 |
| PGEN Precigen Inc | 452,770,308.03 | 4,097,030,694.75 | 5,414,275,522.62 |
| RAPT RAPT Therapeutics Inc | 1,199,104,718.87 | 5,091,215,909.59 | 5,239,610,255.77 |
| XFOR X4 Pharmaceuticals Inc | 2,201,319,793.95 | 4,198,447,197.2 | 5,170,566,103.22 |
| RZLT Rezolute Inc | 287,620,741.69 | 4,890,880,380.9 | 5,015,943,873.33 |
| CTMX CytomX Therapeutics Inc | 1,080,711,700.89 | 4,717,289,977.22 | 5,002,982,287.91 |
| PRQR ProQR Therapeutics NV | 3,965,478,542.24 | 4,130,504,304.58 | 4,613,486,627.9 |
| MNPR Monopar Therapeutics Inc | 4,036,343,919.57 | 4,555,226,216.62 | 4,558,598,441.78 |
| MCRB Seres Therapeutics Inc | 1,506,009,770.57 | 1,628,955,150.26 | 4,535,701,326.94 |
| ABOS Acumen Pharmaceuticals Inc | 1,480,529,190.46 | 4,177,835,115.03 | 4,496,121,070.99 |
| MOLN Molecular Partners AG | 3,270,725,698.22 | 4,327,132,093.37 | 4,453,816,669.16 |
| ACET Adicet Bio Inc | 919,924,814.51 | 3,366,661,163.5 | 4,441,050,139.8 |
| CBIO Crescent Biopharma Inc | 4,212,989,463.76 | 4,254,023,946.37 | 4,371,184,033.06 |
| XLO Xilio Therapeutics Inc | 3,280,355,972.82 | 3,922,902,859.48 | 4,226,551,708.01 |
| ELDN Eledon Pharmaceuticals Inc | 115,990,382.64 | 3,044,423,504.67 | 4,105,250,236.72 |
| CAPR Capricor Therapeutics Inc | 616,793,797.13 | 3,191,448,348.7 | 3,997,169,898.68 |
| AYTU Aytu Biopharma Inc | 1,031,552,517.18 | 2,564,149,344.66 | 3,951,323,506.52 |
| CDXS Codexis Inc | 801,436,955.66 | 2,408,705,160.57 | 3,918,856,315.74 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例